ENTRY       D11004                      Drug
NAME        Vestronidase alfa (USAN/INN);
            Vestronidase alfa (genetical recombination) (JAN);
            Vestronidase alfa-vjbk;
            MepseVII (TN)
PRODUCT     MEPSEVII (Ultragenyx Pharmaceutical)
REMARK      Therapeutic category: 3959
            ATC code: A16AB18
            Product: D11004<JP/US>
EFFICACY    Lysosomal storage disease treatment, Enzyme replacement (beta-glucuronidase)
  DISEASE   Mucopolysaccharidosis VII; Sly syndrome [DS:H00132]
  TYPE      Enzyme replacement therapy product
TARGET      GUSB* [HSA_VAR:2990v1] [HSA:2990] [KO:K01195]
  PATHWAY   hsa04142(2990)  Lysosome
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AB Enzymes
                 A16AB18 Vestronidase alfa
                  D11004  Vestronidase alfa (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Vestronidase Alfa
               D11004  Vestronidase alfa (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               395  Enzyme preparations
                3959  Others
                 D11004  Vestronidase alfa (USAN/INN); Vestronidase alfa (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Glycosidases
                GUSB* [HSA_VAR:2990v1]
                 D11004  Vestronidase alfa (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11004
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11004
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11004
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11004
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D11004
DBLINKS     CAS: 1638194-78-1
            PubChem: 342581841
///
